Virucidal Effect of PVP-I on COVID-19 and as Well as Safety of Its Application on Nasopharynx & Oropharynx

Clinical trial NCT04872686 · COMPLETED

Trial details

NCT number: NCT04872686
Sponsor: DR. MALA KHAN
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Virus Infection, RNA Effect of Drug Efficacy, Self

Start date: 2021-04-10
Primary completion: 2021-05-25
Enrollment: 798

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.